Musclockeletal Ultra-sound Assessment of Pulley Inflammation in Rheumatoid Arthrits Pateints

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

• Ages 18 years and older
• All sexes
• No healthy volunteers
• Adult, Older adult

Study population: Group I: 30 patients with early rheumatoid arthritis. Group II: 30 individuals at risk of rheumatoid arthritis. Group III: 20 healthy age- and sex-matched controls who will be recruited from Rheumatology and Rehabilitation department at Sohag university hospital, 30 of them Early rheumatoid arthritis patients diagnosed according to the 2010 ACR/EULAR criteria with disease duration less or within 1 year, and 30 of them Individuals with clinically suspect arthralgia and positive RF and/or anti-CCP antibodies without clinical evidence of synovitis , and 20 of them Healthy age- and sex-matched controls without rheumatologic disease.

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

About this study

Official title: Ultrasound-detected Pulley Inflammation Across the Rheumatoid Arhritis Continuum: Across Sectional Study

Conditions

Rheumatoid Arthritis (RA)

Medical subject headings

Arthritis, Rheumatoid

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

What is being measured

The primary outcome is the main question the study is designed to answer.

1. Prevalence of Flexor Tendon Pulley Inflammation on Musculoskeletal Ultrasound

   Comparison of the prevalence of flexor tendon pulley inflammation detected by musculoskeletal ultrasound among patients with rheumatoid arthritis, individuals at risk of developing rheumatoid arthritis, and healthy controls

   Measured: 6 months to 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

1. First posted16 Oct 2026
2. Study startSep 2026 (estimated)
3. Primary completionMar 2027 (estimated)
4. Study completionSep 2027 (estimated)

Resources

• Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
• Other trials for Rheumatoid Arthritis (RA)Studies of the same condition, open and under way.
• What the trial phases meanHow a treatment moves from first tests in people to approval.

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.